Lv4
670 积分 2024-02-21 加入
Efficacy of abrocitinib in patients with moderate-to-severe head and neck dermatitis
1天前
待确认
Ivarmacitinib provides rapid and continuous improvement in patients with moderate-to-severe atopic dermatitis: a focus on different anatomical regions
1天前
待确认
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
5天前
已完结
Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study
5天前
已完结
A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis
5天前
已完结
Ivarmacitinib provides rapid and continuous improvement in patients with moderate-to-severe atopic dermatitis: a focus on different anatomical regions
6天前
已完结
Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study
6天前
已完结
Updated consensus guidelines for management of moderate-to-severe atopic dermatitis in Singapore: Integrating biologics, Janus kinase inhibitors and conventional therapies
7天前
已完结
Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo
8天前
已完结
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
15天前
已完结
皖公网安备34019202002308
